Table 1 Patient’s laboratory findings from 2015 to 2022
Year | Glycemia | Lipid profile | Renal panel test | Liver function | Hemogram | Electrolytes |
|---|---|---|---|---|---|---|
2022 | Fasting plasma glucose 209 mg/dL | n.d | Cr 0.8 mg/dL | n.d | n.d | n.d |
2021 | HBA1C 6.5% | HDL-C 53 mg/dL, TG 198 mg/dL, TC 147 mg/dL | n.d | ALT 16, AST 23 | HB 14 g/dL, HTO 83%, PLT 361.000 × 103/µL | n.d |
Fasting plasma glucose 267 mg/dL | ||||||
2020 | HBA1C 6.47% Fasting plasma glucose 187 mg/dL | TC 233 mg/dL, HDL 52 mg/dL, TG 297 mg/dL | Microalbuminuria 1.94, RAC 11.83, Cr 0.8, BUN 27.3 | n.d | n.d | Na 136 mmol/L, K 4.5 mmol/L |
2019 | HBA1C 6.8% Fasting plasma glucose 94 | TC 218 mg/dL, TG 217 mg/dL, LDL-C 118 mg/dL | Cr 0.8 mg/dL | n.d | n.d | Na 140 mmol/L, K 4.77 mmol/L, Cl 102 mg/dL, Mg 1.92 mmol/L, Ca 10.5, P 3.2 mg/dL |
2018 | HBA1C 7.6% | TC 209 mg/dL, HDL 50 mg/dL, TG 480 mg/dL, LDL 118 mg/dL | BUN 24, Cr 0.81 mg/dL | ALT 65.7, AST 42.4 | WBC 14,700, NEU 11.200 × 103/µL, LYMPH 2320, PLT 341.0000 × 103/µL | Mg 1,76 mmol/L, Ca 10,72 mg/dL, P 3.51 mg/dL |
Fasting plasma glucose 97.3 mg/dL | ||||||
2017 | HBA1C 8.3% Fasting plasma glucose 168 mg/dL | TC 189 mg/dL, HDL-C 54 mg/dL, TG 277 mg/dL | Cr 0.73 mg/dL | ALT 90, AST 28 | WBC 9310, HB 12.8 g/dL, HTO 41%, PLT 248.000 × 103/µL | Na 137 mmol/L, K 5.09 mmol/L, Ca 10.5 mg/dL |
2016 | Fasting plasma glucose 242 mg/dL | TC 204 mg/dL, TG 300 mg/dL, LDL-C 102 mg/dL | Cr 0.9 mg/dL | n.d | n.d | n.d |
2015 | HBA1C 8.0% | TC 267 mg/dL, LDL-C 167 mg/dL, HDL-C 59 mg/dL, TG 200 mg/dL | Cr 0.83 mg/dL | n.d | n.d | n.d |